0001724741-18-000001.txt : 20181214 0001724741-18-000001.hdr.sgml : 20181214 20181214100349 ACCESSION NUMBER: 0001724741-18-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20181214 DATE AS OF CHANGE: 20181214 EFFECTIVENESS DATE: 20181214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EpiVax Oncology, Inc. CENTRAL INDEX KEY: 0001724741 IRS NUMBER: 815453645 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-300416 FILM NUMBER: 181234756 BUSINESS ADDRESS: STREET 1: 146 CLIFFORD STREET CITY: PROVIDENCE STATE: RI ZIP: 02903 BUSINESS PHONE: (401)272-2123 MAIL ADDRESS: STREET 1: 146 CLIFFORD STREET CITY: PROVIDENCE STATE: RI ZIP: 02903 D/A 1 primary_doc.xml X0708 D/A LIVE 0001724741 EpiVax Oncology, Inc. 146 CLIFFORD STREET PROVIDENCE RI RHODE ISLAND 02903 (401)272-2123 DELAWARE None None Corporation true 2017 Anne De Groot 146 Clifford Street Providence RI RHODE ISLAND 02903 Executive Officer Director William Martin 146 Clifford Street Providence RI RHODE ISLAND 02903 Executive Officer Director Gad Berdugo 146 Clifford Street Providence RI RHODE ISLAND 02903 Executive Officer Biotechnology Decline to Disclose 06b true 0001724741-17-000002 2017-11-30 true true false 25000 2000000 1405000 595000 false 14 0 true 0 true 0 true false EpiVax Oncology, Inc. /s/ Anne De Groot Anne De Groot President 2018-12-14